Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
17 Pág.
| Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2023 |
| Country: | España |
| Institution: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repository: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/349371 |
| Online Access: | http://hdl.handle.net/10261/349371 https://api.elsevier.com/content/abstract/scopus_id/85180695762 |
| Access Level: | Open access |
| Keyword: | COVID-19 MVA-based vaccine S protein SARS-CoV-2 Efficacy Immunogenicity Mice Variants of concern |
| Summary: | 17 Pág. |
|---|